Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single Dose Escalation Study in Patients With Chronic Heart Failure

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: October 31, 2007
Last updated: August 9, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2009
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Acute hemodynamic response to single oral doses of BAY 60-4552, a soluble guanylate cyclase stimulator, in patients with biventricular heart failure. V Mitrovic, B Swidnicki, A Ghofrani, W Mück, N Kirschbaum, J Mittendorf, J-P Stasch, G Wensing, R Frey, S Lentini. BMC Pharmacology 2009; 9(Suppl 1): P51.